Osaka, Japan

Shigeki Kuwahara

This inventor holds 3 USPTO granted patents. Top assignees: The Green Cross Corporation, Welfide Corporation. Active years: 1994-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shigeki Kuwahara. Retrieved from https://idiyas.com/inventor/shigeki-kuwahara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.9

ph-index = 3

Forward Citations = 68(Granted Patents)


Location History:

  • Hirakata, JP (1994)
  • Osaka, JP (1998 - 2003)

Company Filing History:


Years Active: 1994-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Shigeki Kuwahara: Innovator in Pharmaceutical Research

Introduction

Shigeki Kuwahara is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical research, particularly in the development of inhibitors for various diseases. With a total of 3 patents to his name, Kuwahara's work has the potential to impact the medical community significantly.

Latest Patents

Kuwahara's latest patents include innovative solutions such as IgE antibody production inhibitors and autoimmune disease inhibitors. He has also developed a triazole derivative and its pharmaceutical use, showcasing his expertise in creating effective treatments for complex health issues.

Career Highlights

Throughout his career, Shigeki Kuwahara has worked with reputable companies, including The Green Cross Corporation and Welfide Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Kuwahara has collaborated with esteemed colleagues, including Chikara Fukaya and Masahiko Kajii. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Shigeki Kuwahara's contributions to pharmaceutical research and his innovative patents highlight his role as a significant figure in the field. His work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…